1. Home
  2. LNKB vs TSVT Comparison

LNKB vs TSVT Comparison

Compare LNKB & TSVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LNKB
  • TSVT
  • Stock Information
  • Founded
  • LNKB 2018
  • TSVT 2021
  • Country
  • LNKB United States
  • TSVT United States
  • Employees
  • LNKB N/A
  • TSVT N/A
  • Industry
  • LNKB
  • TSVT Biotechnology: Pharmaceutical Preparations
  • Sector
  • LNKB
  • TSVT Health Care
  • Exchange
  • LNKB Nasdaq
  • TSVT Nasdaq
  • Market Cap
  • LNKB 236.7M
  • TSVT 253.9M
  • IPO Year
  • LNKB N/A
  • TSVT N/A
  • Fundamental
  • Price
  • LNKB $6.24
  • TSVT $4.87
  • Analyst Decision
  • LNKB Hold
  • TSVT Buy
  • Analyst Count
  • LNKB 1
  • TSVT 6
  • Target Price
  • LNKB $7.50
  • TSVT $10.40
  • AVG Volume (30 Days)
  • LNKB 43.5K
  • TSVT 318.2K
  • Earning Date
  • LNKB 10-25-2024
  • TSVT 11-12-2024
  • Dividend Yield
  • LNKB 4.80%
  • TSVT N/A
  • EPS Growth
  • LNKB N/A
  • TSVT N/A
  • EPS
  • LNKB N/A
  • TSVT N/A
  • Revenue
  • LNKB $68,142,000.00
  • TSVT $44,120,000.00
  • Revenue This Year
  • LNKB N/A
  • TSVT N/A
  • Revenue Next Year
  • LNKB $4.03
  • TSVT $22.42
  • P/E Ratio
  • LNKB N/A
  • TSVT N/A
  • Revenue Growth
  • LNKB 101.22
  • TSVT N/A
  • 52 Week Low
  • LNKB $5.86
  • TSVT $1.54
  • 52 Week High
  • LNKB $8.29
  • TSVT $6.40
  • Technical
  • Relative Strength Index (RSI)
  • LNKB 45.31
  • TSVT 50.57
  • Support Level
  • LNKB $6.17
  • TSVT $4.60
  • Resistance Level
  • LNKB $6.46
  • TSVT $4.90
  • Average True Range (ATR)
  • LNKB 0.15
  • TSVT 0.32
  • MACD
  • LNKB -0.01
  • TSVT -0.00
  • Stochastic Oscillator
  • LNKB 13.79
  • TSVT 59.09

About LNKB LINKBANCORP Inc.

Linkbancorp Inc operates in the banking industry. It provides banking services for individuals and businesses such as commercial lending, non-profit banking, treasury management, deposits and loans.

About TSVT 2seventy bio Inc.

2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.

Share on Social Networks: